CA 125 in benign gynecological conditions

被引：91

作者：

Meden, H ^{[1
]}

Fattahi-Meibodi, A ^{[1
]}

机构：

[1] Univ Gottingen, Dept Obstet & Gynecol, D-37075 Gottingen, Germany

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1998年 / 13卷 / 04期

关键词：

CA; 125; pregnancy; pelvic inflammatory disease;

D O I：

10.1177/172460089801300411

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The tumor marker CA 125 was initially thought to be specific for ovarian malignancies. Subsequently it was found to be raised in a variety of benign conditions, including pregnancy, pelvic inflammatory disease, tuberculosis and cirrhosis of the liver With respect to gynecological tumors, CA 125 may be elevated in benign ovarian cysts, tubo-ovarian abscess, endometriosis, hyperstimulation syndrome, ectopic pregnancy and fibroids. These results demonstrate that CA 125 is a marker of non-specific peritoneal conditions.

引用

页码：231 / 237

页数：7

共 51 条

[1] WHAT IS A NORMAL CA125 LEVEL [J].

ALAGOZ, T ;

BULLER, RE ;

BERMAN, M ;

ANDERSON, B ;

MANETTA, A ;

DISAIA, P .

GYNECOLOGIC ONCOLOGY, 1994, 53 (01) :93-97

[2]

BARBIERI RL, 1986, FERTIL STERIL, V45, P630

[3] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].

BAST, RC ;

KLUG, TL ;

STJOHN, E ;

JENISON, E ;

NILOFF, JM ;

LAZARUS, H ;

BERKOWITZ, RS ;

LEAVITT, T ;

GRIFFITHS, CT ;

PARKER, L ;

ZURAWSKI, VR ;

KNAPP, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887

[4] REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].

BAST, RC ;

FEENEY, M ;

LAZARUS, H ;

NADLER, LM ;

COLVIN, RB ;

KNAPP, RC .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337

[5] WHAT DO WE KNOW ABOUT THE ORIGIN OF CA-125 [J].

BISCHOF, P .

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 49 (1-2) :93-98

[6] PERIPHERAL CA-125 LEVELS IN PATIENTS WITH UTERINE FIBROIDS [J].

BISCHOF, P ;

GALFETTI, MA ;

SEYDOUX, J ;

VONHOSPENTHAL, JU ;

CAMPANA, A .

HUMAN REPRODUCTION, 1992, 7 (01) :35-38

[7] SERUM CA-125 IN EPITHELIAL OVARIAN-CANCER - A LONGITUDINAL-STUDY [J].

BRIOSCHI, PA ;

IRION, O ;

BISCHOF, P ;

BADER, M ;

FORNI, M ;

KRAUER, F .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (03) :196-201

[8] SERUM CONCENTRATION OF PROTEIN CA-125 IN WOMEN WITH PELVIC INFLAMMATORY DISEASE [J].

BRUMSTED, JR ;

MEAD, PB ;

GIBSON, M .

SEXUALLY TRANSMITTED DISEASES, 1988, 15 (03) :144-147

[9] OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER [J].

CANNEY, PA ;

MOORE, M ;

WILKINSON, PM ;

JAMES, RD .

BRITISH JOURNAL OF CANCER, 1984, 50 (06) :765-769

[10] CLINICAL VALIDATION OF THE NEW ELSA-CA-125-II ASSAY - REPORT OF A EUROPEAN MULTICENTER EVALUATION [J].

CLEMENT, M ;

BISCHOF, P ;

GRUFFAT, C ;

RICOLLEAU, G ;

AUVRAY, E ;

QUILLIEN, V ;

PACHECO, C ;

TORRES, M ;

FERDEGHINI, M .

INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) :199-203

← 1 2 3 4 5 6 →